[Ohio] Specialty pharmacy updates
Summary
Anthem Blue Cross and Blue Shield Ohio is implementing new prior authorization requirements and step therapy protocols for specialty pharmacy oncology medications effective January 1, 2027. Starting that date, providers must request prior authorization for Avgemsi (gemcitabine), Docivyx (docetaxel), and Beizray (docetaxel) before dispensing, and must follow step therapy requirements for pemetrexed, bendamustine, and docetaxel products, with preferred and non-preferred formulations designated.
Get alerts when payers change rules like this one
We check Anthem BCBS and other payers every day and email you when a change matches your specialty and state.